Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  GEA Group AG    G1A   DE0006602006

GEA GROUP AG

(G1A)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Time is pressing: The new GEA Pharma Separator line "aseptic" with highest cleaning standards supports the vaccine manufacturer Sinovac in the fight against COVID-19

11/29/2020 | 03:09pm EST
GEA Pharma Separator skid aseptic C with fully automatic SIP: Steam-sterilizable and completely sealed, designed for maximum biosafety and containment. (Photo: GEA)

In order to be able to produce a vaccine against the corona virus Sars-CoV-2 in large quantities, quickly and safely, GEA is supplying further separator systems to the Chinese biopharmaceutical company Beijing Sinovac Life Sciences. The state-of-the-art centrifuge skid units of the 'GEA Pharma Separator aseptic C' series are manufactured according to ASME BPE standards and meet the highest hygienic pharmaceutical requirements with SIP (Sterilizing-In-Place) and CIP (Cleaning-In-Place) cleanability.

The aseptic C line covers a wide capacity range with four bowl sizes. The machines feature a water-cooled and thus emission-free Integrated Direct Drive (IDD) for the highest cleanroom classes. With the CIP cleaning system and the SIP sterilization concept, the machines are an essential part of the demanding production of vaccines - as well as many other pharmaceutical products. 'All the drama surrounding the global impact of COVID-19 means that we, as a leading supplier of equipment, process technologies and process solutions, have a special obligation, especially in the pharmaceutical sector, to support our customers in the production of vaccines with reliable, fast and high-quality technological solutions and our decades of experience,' says Dr. Markus Kühberger, Director of the Chemical & Pharma Business Line, GEA. 'The plug & produce Pharma Separator Skid Units aseptic from GEA are optimally designed for both standard and customized requirements to ensure maximum safety, maximum yield and perfect adaptation to the respective customer process,' says Kühberger.

New line as a world first and next step in vaccine production - aseptic processing made easy

With the introduction of the new pharmaceutical separator line 'aseptic', GEA offers pharmaceutical customers a new level of performance, clean room protection, validation and cleanability, as now in the Sinovac project. As a result, every aseptic process can reach the next level of safety.

Four different bowl sizes for each capacity - optimum yield with optimized bowl design

With four different bowl sizes, the capacity of each customer process can be met. Depending on the product, the four bowl sizes are suitable for processing capacities of up to 12000 l/h. The bowl design is conceived with a highSigma variant (large clarifying area, small solids space) for up to 5 vol% or a highVol separator bowl variant (larger solids space) for solids up to 10 vol%. This enables an optimal yield by adapting to the respective product to be processed.

Smooth handling

Shear-sensitive products are gently fed to the filled drum by the patented hydrohermetic feed system below the liquid level and gently accelerated at the axis of rotation.

Integrated direct drive for high clean room classes

The new state-of-the-art IDD drive with a water-cooled motor and a closed housing prevents particle emissions into the clean room. Fewer parts mean fewer wearing parts and easier machine maintenance.

GEA supplied separator to Sinovac already in summer 2020

Already in July 2020, Separation & Flow Components Technologies business unit delivered a CSC 6 centrifuge to Sinovac Life Sciences. This is also a disc centrifuge. GEA developed the machine for the pharmaceutical biotechnology industry according to the current cGMP ('Clinical Good Manufacturing Practice') requirements. The CSC 6 machine is manufactured in a steam sterilizable version (SIP up to 2.5 bar/137°C) for aseptic processing. It has a fully automatic on-site cleaning program (CIP, 'Clean-in-Place') and is designed in a hygienic, highly polished design. The hydrohermetic inlet system patented by GEA ensures gentle treatment of shear-sensitive products. The plant is driven by a 3-phase alternating current motor. All parts in contact with the product are made of high-alloy stainless steels. The seals comply with FDA and USP Class VI requirements.

At a glance:

The scope of the GEA Pharma Separator 'aseptic' line

  • Clarifier skid for solids contents of 5 to 10 vol%
  • Nozzle separator skid unit with new GEA flexicon nozzle for solids contents of 10 to 35 vol% and even more, depending on the product. Infinitely adjustable even during production.
  • Separator Skid Unit with GEA flexChange concept for solids contents from 5 to 35 Vol% and more, depending on the product. Transforms a static process line into a flexible one.

Features and benefits

  • High separation and separation efficiency
  • Gentle product handling in the inlet
  • Automatic SIP
  • Automatic CIP
  • Hygienic surface design
  • ASME BPE Design
  • Patented laser-welded plate lugs (gap-free)
  • large capacity range, two basic versions, four drum sizes
  • Integrated direct drive IDD

Disclaimer

GEA Group AG published this content on 24 November 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 November 2020 20:08:01 UTC


© Publicnow 2020
All news about GEA GROUP AG
07:17aGEA GROUP : Goldman Sachs reiterates its Neutral rating
MD
01/15GEA GROUP : Morgan Stanley reaffirms its Neutral rating
MD
01/13GEA GROUP AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the..
EQ
01/12GEA GROUP : JP Morgan remains a Sell rating
MD
01/12GEA GROUP : Deutsche Bank gives a Neutral rating
MD
01/11GEA : The new GEA PowerPak PLUS technology – now with more sustainable pac..
PU
01/07GEA GROUP : Gets a Sell rating from JP Morgan
MD
01/04GEA : closes sale of barn and milk cooling technology businesses
PU
01/04GEA GROUP AKTIENGESELLSCHAFT : GEA closes sale of barn and milk cooling technolo..
EQ
01/04PRESS RELEASE : GEA Group Aktiengesellschaft: GEA closes sale of barn and milk c..
DJ
More news
Financials
Sales 2020 4 679 M 5 650 M 5 650 M
Net income 2020 163 M 196 M 196 M
Net Debt 2020 8,98 M 10,8 M 10,8 M
P/E ratio 2020 32,0x
Yield 2020 2,82%
Capitalization 5 440 M 6 570 M 6 569 M
EV / Sales 2020 1,16x
EV / Sales 2021 1,12x
Nbr of Employees 18 248
Free-Float 91,5%
Chart GEA GROUP AG
Duration : Period :
GEA Group AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GEA GROUP AG
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 21
Average target price 30,10 €
Last Close Price 30,01 €
Spread / Highest target 23,3%
Spread / Average Target 0,32%
Spread / Lowest Target -23,4%
EPS Revisions
Managers and Directors
NameTitle
Stefan Klebert Chairman-Executive Board
Helmut Perlet Chairman-Supervisory Board
Johannes Giloth Chief Operating Officer
Marcus A. Ketter Chief Financial Officer
Hartmut Eberlein Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
GEA GROUP AG2.49%6 549
ATLAS COPCO AB8.31%63 496
FANUC CORPORATION6.03%50 867
PARKER-HANNIFIN CORPORATION4.68%36 730
SANDVIK AB8.49%32 717
STANLEY BLACK & DECKER, INC.-3.32%27 659